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The American Society of Transplant Surgeons (ASTS) PROviding better Access To 
Organs (PROACTOR) Task Force was created to inform ongoing ASTS organ access 
efforts. Task force members were charged with comprehensively cataloguing current 
organ access activities and organizing them according to stakeholder type. This white 
paper summarizes the task force findings and makes recommendations for future 
ASTS organ access initiatives.
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1  | INTRODUCTION
Organ transplantation is fundamentally limited by the availability of 
transplantable organs. In the United States, 22 people die each day 
because they do not have access to a life- saving organ.1 Previous 
attempts to respond to this public health crisis have demonstrated 
that concentrated, multistakeholder efforts with strong leader-
ship can increase organ availability. In 2003, the Donation and 
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Transplantation Community of Practice (DTCP) was formed to en-
gage in Breakthrough Collaborative initiatives using the principles of 
metric identification, joint accountability, and best practice applica-
tion to increase deceased donor organ donation.2,3 The immediate 
post- Collaborative period was marked by a striking increase in de-
ceased donors from 6457 donors in 2003 to 8017 donors in 2006.4 
Despite this encouraging increase, organ donation growth in the 
post- Collaborative period stagnated, with deceased donor volumes 
oscillating around the 8000 donor/year mark for nearly a decade. 
The past 2 years have seen a substantial increase in deceased donor 
activity, with 9079 donors in 2015 and 9970 in 2016, due in part 
to the increase in deaths associated with opioid use.5 Despite this 
apparent success, 12 192 people were removed from the waitlist in 
2016 due to death or becoming too sick to undergo transplantation6 
(Figure 1).
Expanding access to transplantation by increasing deceased dona-
tion, living donation, and organ utilization is a central component of 
the American Society of Transplant Surgeons (ASTS)’s vision of “saving 
and improving lives with transplantation.” Accordingly, in 2015, ASTS 
President Charles Miller, MD, commissioned the ASTS PROviding 
better Access To Organs (PROACTOR) Task Force. The charge of this 
task force is to identify mechanisms through which the ASTS and its 
membership can effect change to reduce, and eventually resolve, the 
critical organ shortage.
The initial goal of the task force was to develop a comprehen-
sive understanding of current organ access initiatives implemented 
by stakeholders within the United States and internationally. 
To create this catalogue, stakeholders were categorized accord-
ing to type and assigned to task force members who performed 
literature reviews, Internet searches, and personal inquiries to 
identify organ access initiatives in a wide variety of arenas. These 
broad catalogues were then reviewed by the task force lead-
ership, with highlights organized and summarized in this white 
paper. Additionally, considerations are presented for future 
application of ASTS efforts and resources toward achieving the so-
ciety’s mandate to eliminate mortality on the waitlist due to organ 
unavailability.
2  | OVERVIEW OF INITIATIVES BY 
STAKEHOLDER GROUP
2.1 | ASTS
In 2015, the ASTS increased its efforts dedicated to organ access, 
including the creation of the PROACTOR Task Force and the dedi-
cation of the 16th and 17th annual Winter Symposia to the theme 
of increasing organ availability. These efforts continued in 2016 
with ASTS participation in the White House Organ Summit, as well 
as partnership with the Laura and John Arnold Foundation and the 
American Society of Transplantation (AST) to solicit novel metrics to 
reduce risk- aversion within transplant centers.7,8 Finally, in 2017, the 
ASTS created the ASTS Donation after Circulatory Determination of 
Death (DCDD) Task Force to help standardize organ recovery and 
utilization protocols to improve the use of this growing category of 
organ donor.
At the committee level, the ASTS has taken a multifaceted ap-
proach to organ availability. In 2009, the Ethics Committee published 
“Stimulus for Organ Donation: A Survey of the American Society of 
Transplant Surgeons Membership,” delineating member views on ac-
ceptable and unacceptable strategies to increase organ donation.9 The 
same year, the Ethics and Executive Committees published a response 
to the Declaration of Istanbul, outlining the society’s strong support 
for the principles outlined in the declaration and discussing poten-
tial obstacles to implementation in the United States.10 The Ethics 
Committee has also developed ASTS positions on conscious DCDD11 
and kidney paired donation.12
The ASTS Scientific Studies Committee is currently engaged in 
developing a research grant to assist ASTS members in conducting 
F IGURE  1 Timeline demonstrating US 
deceased donor and living donor volumes, 
waitlist deaths and removals for “too sick 
to transplant,” and start- of- year waitlist for 
all organs
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single- center or multicenter studies on organ donors, transplant recip-
ients of expanded criteria donors, donation after circulatory determi-
nation of death, and living donation. The Scientific Studies Committee 
also partnered with the Ethics and Standards and Quality Committees 
to propose draft guidelines that address barriers to deceased donor 
research and complexities regarding consent from donors, transplant 
recipients, and providers.
The ASTS Living Donation Committee has outlined best practices 
for the long- term care of living donors and developed informational 
materials to be distributed to living donors. Further, the ASTS partic-
ipates in the administration of the National Living Donor Assistance 
Center, currently the most comprehensive mechanism for reducing 
financial disincentives to living organ donation.13
The Government and Scientific Liaison Committee provides 
ASTS representation on the Organ Procurement and Transplantation 
Network (OPTN)/United Network for Organ Sharing (UNOS) Board 
of Directors, which participates in developing organ donation policies 
for the OPTN. The Legislative Committee has compiled an extensive 
library of advocacy letters that are available to the public on the ASTS 
website, many of which support initiatives aimed at increasing organ 
availability. Furthermore, the Legislative Committee played a key 
role in the passage of the HIV Organ Policy Equity Act in 2013.14,15 
Organ donation is a key component of the National Transplant Surgery 
Fellowship Curriculum, developed by the Curriculum Committee to 
educate ASTS Abdominal Transplant Fellows. Last, the Diversity Issues 
Committee has developed an Educational Materials for Minorities 
page housed on the ASTS website.16 This webpage contains ASTS ed-
ucational videos in Spanish on living kidney and liver donation. It also 
includes other websites specifically designed to help the Hispanic/
Latino community make informed treatment decisions about kidney 
donation and transplantation by providing resources and neutral 
information.
2.2 | US and international transplant societies
The US transplant societies compose a large, diverse, impactful group 
of organizations that have a foundational mission to improve and aug-
ment organ transplantation. As expected, the missions and initiatives 
of these societies overlap with each other and with the mission and 
initiatives of the ASTS.
AST is the largest transplant organization in North America, 
with more than 3300 members.17 AST influences organ access 
through provider education, patient information, and public policy 
initiatives. Accordingly, AST dedicated the 2016 Cutting Edge of 
Transplantation Meeting to resolving the organ shortage through 
practice, policy, and politics.18 Several important living donation 
initiatives are contained within the AST Live Donor Community of 
Practice. This specialty- focused group within AST provides multi-
disciplinary provider education via online communities and webi-
nars, including a series of web- based educational modules called 
“Maximizing Your Living Donor Program.” AST has also developed a 
Live Donor Toolkit aimed at increasing awareness and education for 
living donation.19
As the professional organization linking all 58 US organ procure-
ment organizations (OPOs), the Association of Organ Procurement 
Organizations (AOPO) promotes their vision that “those in need of 
a transplant receive donated organs or tissues in a timely manner in 
order to end deaths on the waiting list.”20 AOPO supports organ access 
through educational activities for organ procurement professionals, as 
well as government advocacy on the behalf of OPOs. AOPO operates 
a voluntary, peer- review accreditation process designed to help OPOs 
improve performance.21 Further, AOPO publishes the “WikiDonor” 
online donor management handbook to serve as a resource for donor 
management by OPO staff.22
NATCO, the Organization for Transplant Professionals, unites a 
diverse group of transplant professionals ranging from procurement 
practitioners, hospital development specialists, and transplant center 
nurses and allied health staff.23 NATCO’s contributions to organ ac-
cess are primarily derived from educational support to improve the 
performance of members involved with deceased donation and donor 
management. NATCO has recently become more involved with advo-
cacy related to organ access issues, particularly support of the Living 
Donor Protection Act.24
Other national transplant- specific organizations, including the 
American Foundation for Donation and Transplantation,25 promote 
organ donation as part of their core mission. Additionally, local and 
regional transplantation societies, the largest of which is the Texas 
Transplantation Society, promote organ donation through state- level 
advocacy and state legislation initiatives to complement larger, na-
tional initiatives.26
International transplant societies provide a common link for the 
often disparate practices of organ transplantation throughout the 
world. The Transplantation Society (TTS) is the largest international 
transplant society and has been particularly instrumental in support-
ing the Declaration of Istanbul and other ethical efforts in transplanta-
tion. The TTS sponsors several novel initiatives dedicated to increasing 
organ access, including the “Transplantation for Schools” program, 
which provides a pragmatic toolkit for teachers to educate students 
about organ donation in an age- appropriate manner.27
2.3 | US medical societies
Medical and surgical societies play an integral role in uniting physi-
cians along specialty lines and providing support for research and 
clinical practice, along with a political voice. The majority of practicing 
US physicians are members of 1 or more societies, with a trend toward 
increasing membership in specialty societies and decreasing member-
ship in general physician societies.28 Most societies are either disci-
pline specific or disease specific and provide information for patients 
and providers regarding transplantation as an option for the relevant 
end- stage disease. However, most of these societies currently provide 
only cursory education and policy initiatives with respect to increas-
ing organ availability. A notable exception is the American Society of 
Nephrology (ASN), a strong advocate for living kidney donation that 
recently was a vocal supporter of the Living Donor Protection Act of 
2016.29
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Nearly all deceased donors are cared for in an intensive care set-
ting. Accordingly, The Society of Critical Care Medicine (SCCM) and 
the American College of Chest Physicians are ideal partners for efforts 
directed at recognition and referral of potential donors, application 
of donor management guidelines, and opportunities for future re-
search in deceased donor interventions.30,31 Both societies are active 
in improving deceased donor management through both educational 
initiatives as well as a consensus statement regarding intensive care 
of potential organ donors in partnership with AOPO.32 Additionally, 
SCCM partnered with AOPO, UNOS, The American Thoracic Society, 
and the International Society of Heart and Lung Transplantation to cre-
ate an official ethical and policy considerations document concerning 
DCDD.33
2.4 | OPOs, UNOS, and donor registries
The core purpose of the 58 US OPOs is to facilitate deceased donor 
organ donation within a designated donor service area. OPOs are 
driven both intrinsically by their mission and extrinsically by regula-
tory bodies to increase organ availability. Accordingly, OPOs are es-
sential partners for any initiatives aimed at increasing deceased donor 
organ availability and use.
OPOs are the most visible and well- resourced entities promoting 
awareness and understanding of deceased donation at the local level. 
OPOs sponsor public events, minority outreach programs, and com-
munity and business partnerships aimed toward increasing deceased 
donation. Most of these efforts currently involve drives to join state 
donor registries. State donor registries are authorized via state legisla-
tive code and are, in most cases, operated independently of the OPOs 
themselves or the state government. Currently, each state has its own 
donor registry without a cohesive, national service; however, Donate 
Life America provides a common online portal for individuals to regis-
ter themselves in their appropriate state.34
Innovations in deceased donation require close collaboration 
among OPOs, donor hospitals, and transplant center groups. Donor 
intervention trials designed to improved donor organ quality exemplify 
this cooperative relationship. For example, the 2015 investigation of 
the effect of therapeutic donor hypothermia on kidney graft function 
was facilitated by partnership between academic centers in California 
and Oregon with large OPOs in California.35 Donor intervention tri-
als present unique ethical and logistical challenges that are currently 
being examined by The National Academy of Medicine (formerly 
Institute of Medicine) via a multistakeholder Committee on Issues in 
Organ Donor Intervention Research, which includes strong represen-
tation from OPOs.36
Novel approaches that challenge the traditional donation model 
also arise from multistakeholder collaboration led by OPOs. In St. 
Louis, MO, the partnership between Mid- America Transplant Services 
and the local transplant centers manifested in the creation of a free- 
standing donation facility where more than 90% of donors in the 
donation- service area are transferred. This departure from the tradi-
tional deceased donation model has been shown to result in higher 
donor organ yield and lower cost.37 Other OPOs have begun using 
similar donation facilities, including Gift of Life Michigan,38 Center for 
Organ Recovery and Education in Pittsburgh,39 and Donor Alliance in 
Denver.40
Although OPOs have traditionally focused on deceased donation, 
several OPOs have engaged in activities related to living donation. In 
2004, the transplant centers and OPOs comprising UNOS Region 1 re-
ported their experience with a two- tiered kidney exchange program.41 
This program facilitated exchanges between incompatible live donor 
pairs within the region and allowed incompatible donors to donate to 
the waitlist in exchange for high priority for their intended candidate 
to receive a deceased donor kidney. In 2005, the Washington Regional 
Transplant Community OPO published a description of their OPO- 
administered nondirected living kidney donor program. This program 
increased the OPO- procured kidney organ pool by 5%.42 More re-
cently, the 4 California OPOs working together under the Donate Life 
California organization launched Living Donation California in 2013.43 
This state- authorized information and referral service provides educa-
tion about living donation and helps refer nondirected living donors to 
local transplant centers.
As the contract administrator of the OPTN, UNOS is an essential 
component of the US deceased donation system. UNOS provides 
the infrastructure required for deceased donation and organ alloca-
tion and provides education and awareness about organ donation 
on a national scale. UNOS also administers Health Resources and 
Services Administration (HRSA)/OPTN- directed initiatives includ-
ing task forces geared toward increasing deceased donation and 
organ use. OPTN Task 6, the Deceased Donor Potential Study, was 
commissioned in 2010 with the goal of identifying the true larger 
potential for deceased organ donation in the United States. This 
study estimated the true donor potential in the United States to 
be between 35 000 and 40 000 donors per year, a striking number 
that finds most unrealized potential in deaths of individuals aged 
50 to 75 years.44 More recently, OPTN Task 18, also known as the 
Collaborative Innovation and Improvement Network (COIIN) proj-
ect, was established with the goal of using alternative monitoring of 
transplant programs to reduce risk- avoidance behaviors with respect 
to kidney graft use.
2.5 | Nonprofit organizations
A large number of nonprofit organizations dedicated to increasing 
deceased donation by creating awareness are present on the local, 
regional, and national levels. Several large, event- based organizations 
such as Transplant Games of America45 generate sufficient media at-
tention to positively affect organ donation awareness. Other large, 
national organizations such as The American Transplant Foundation 
also have the resources and scope to affect donation registrations.46 
Select smaller organizations may also have a large impact on aware-
ness via large- scale media, including Donate Life Hollywood, which 
aims to eliminate donation misconceptions such as the “stolen- kidney” 
storyline from television and film.47
The majority of organ donation awareness organizations are 
small organizations that operate at the local or regional level, often 
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in memory of a deceased organ donor. Although these organizations 
share similar missions and goals, there is limited coordination be-
tween these groups that would serve to synergize their effect toward 
increasing organ donation. Considerable resources are donated to 
and invested in these organizations for both operational and mission- 
directed purposes, yet the overall impact of these organizations with 
respect to increasing organ availability through awareness is difficult 
to measure.
A few national organizations have the scope and resources to ef-
fect change by influencing policy or promoting disruptive approaches 
to increasing deceased donation. One such organization, ORGANize, 
has created a social media–based platform for donor registration using 
the concept of “social declaration,” which has been implemented in six 
states.48 This 21st- century method of registering first- person intent 
seeks to become a modern alternative to the association between 
organ donor registration and motor vehicle licensure. More contro-
versially, the LifeSharers organization promoted a “closed system” of 
organ donation to other designated LifeSharer members but ceased 
operations in March 2016.49
Recognizing the disparity between minority transplant candidate 
listings and minority deceased donation, several organizations have 
sought to bridge this gap through community education initiatives. 
These efforts are spearheaded by large national organizations, in-
cluding the Association for Multicultural Affairs in Transplantation50 
and the National Minority Organ and Tissue Transplant Education 
Program,51 as well as smaller local organizations and OPOs. Further, 
as the Hispanic population increases dramatically in some parts of the 
United States, the explicit support of organ donation by Pope Francis 
as outlined in the Catechism of the Catholic Church is increasingly 
important.52
Philanthropic organizations have demonstrated interest in the on-
going organ shortage and seek to improve access to organ transplan-
tation via the funding of novel projects. The Laura and John Arnold 
Foundation is a notable supporter of organ access initiatives, including 
cosponsorship of the ASTS/AST project to improve transplant center 
metrics with the goal of reducing risk- averse behavior by transplant 
centers.8 In addition, the Arnold Foundation announced $4.2 million in 
funding for deceased donor intervention trials to improve organ utili-
zation as part of the 2016 White House Organ Summit.53
Non- profit organizations support living donation through several 
different mechanisms. The National Kidney Registry and the Alliance 
for Paired Donation facilitate living kidney donation and transplan-
tation through paired exchange.54,55 The National Kidney Registry 
is notable for an “Advanced Donation Program,” which provides 
“vouchers” that allow the living donation event to be uncoupled in 
time from the recipient’s transplantation.56,57 Several other organi-
zations attempt to increase living donation through education, donor 
support, and awareness. Notable examples in this category include 
Explore Transplant,58 which provides educational programs to help 
potential donors make informed decisions; The John Brockington 
Foundation,59 which sponsors a “Connect to Transplant” coaching 
program for former living donors to serve as donor champions; the 
Kidney Exchange Connection,60 which provides peer support from 
prior living donors; and Renewal,61 which facilitates directed and al-
truistic living kidney donation. Additionally, Transplant First Academy 
is dedicated specifically to helping kidney patients avoid dialysis via 
a preemptive living donor transplant through educational materials 
and events.62 Finally, several organizations seek to increase living 
donation via advocacy and policy change. This category is high-
lighted by Waitlist Zero, which is active in national living donation 
legislative efforts and leads the Coalition to Promote Living Kidney 
Donation with the intention of sponsoring a future Living Donation 
Breakthrough Collaborative.63
2.6 | Transplant center initiatives
Individual transplant centers can have an impact on organ access in 
primary ways. The first impact is through more effective utilization of 
organs that might otherwise go unused.64,65 Specific centers success-
fully use deceased donor organs such as pediatric en-bloc kidneys,66 
kidneys from donors with severe acute kidney injury,67 and DCDD 
liver68,69 and lung70 allografts at rates that far exceed those of many 
other programs. Centers have developed advanced surgical tech-
niques to improve utilization of dual lower- quality adult kidneys71 and 
to create two adult transplants from a single liver allograft.72 Further, 
centers differ markedly in their utilization of living donor organs in-
cluding living donor liver allografts and incompatible living donor kid-
ney transplants.73,74
The second mechanism individual transplant centers can use to 
have an impact on organ availability relates to novel initiatives directed 
toward increasing living donation volume. The Johns Hopkins Live 
Donor Champion program increases living kidney donation by training 
a friend or family member to advocate on behalf of a transplant candi-
date.75 The Beth Israel Deaconess “House Calls” program may reduce 
racial disparities in access to living donor kidney transplantation.76,77 
The Northwestern Hispanic Transplant Program incorporates a num-
ber of initiatives, including the development of the bilingual website 
informate.org, which provides culturally competent education about 
living donation.78-80
2.7 | Industry
Organ preservation is the biomedical industry’s primary contribution 
to organ availability. Historically, the development of organ preserva-
tion solutions enabled the prolongation of organ storage times, re-
sulting in the ability to match donor organs with distant recipients.81 
Further innovations include the production of cold pulsatile- perfusion 
devices for deceased donor kidneys, albeit with unclear effects on 
utilization.82 Current industry advances include expanded applica-
tion of extrarenal ex vivo perfusion devices, including hypothermic 
and normothermic perfusion devices for liver allografts. Hypothermic 
machine perfusion of “orphan” liver allografts has been shown to im-
prove patient survival and decrease biliary complications.83 Similarly, 
normothermic- perfusion devices have been shown to decrease 
 ischemia–reperfusion injury in porcine models of liver transplanta-
tion, and encouraging early results from the use of this technology 
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in human liver transplantation may represent another avenue for the 
improved utilization of donor livers.84-87
Partnerships with information technology firms may provide 
novel pathways for increasing both deceased and living dona-
tion. A 2012 collaboration between Johns Hopkins University and 
Facebook generated 13 054 new organ donor registrations in a sin-
gle day, demonstrating the massive potential of social media as a 
driver of societal change.88 This collaboration was brought into the 
live donation space in 2014 with the development of a smartphone 
app designed to help candidates identify possible living donors.89 
Technology- driven donor registration was boosted in late 2016 
when Apple, in conjunction with Donate Life America, provided sim-
ple, integrated donor- registration technology with the release of the 
iPhone OS10 software.90 Other, transplant- specific technology plat-
forms may have the potential to increase living donation by reduc-
ing barriers to donor application. These products include BREEZE 
Transplant, a web- based patient- intake and decision- support portal 
that has been shown in a large center to increase living donation 
volume by 15%.91
Private insurance companies are key industry stakeholders in 
transplantation, and their relevance to organ access primarily relates 
to their ability to facilitate living donation. For example, in 2016, 
UnitedHeathcare announced coverage for travel expenses related to 
living kidney donation.92
2.8 | International initiatives
Deceased donors per million people (PMP) is an imperfect statis-
tic,93 but it is currently the most widely used method of comparing 
donation rates around the world. In 2015, the United States ranked 
sixth in the world with 28.5 deceased donors PMP, behind Portugal, 
Belgium, Iceland, Croatia, and Spain94 (Figure 2). With a donation 
rate of 39.7 donors PMP in 2015, the Spanish organ donation sys-
tem is often viewed as the world’s gold standard. Much discussion 
of the Spanish system centers on the “opt- out” system of presumed 
consent. However, several countries have adopted similar programs 
with varying results, including Brazil and France, which both experi-
enced decreased deceased donation after the implementation of a 
presumed- consent system.95 Close examination of the Spanish organ 
donation system reveals that their success results from effective uti-
lization of older donors, with more than 50% of donors older than 
60 years and 30% older than 70, as well as development of a highly 
prioritized donation culture and practice imbedded within the health 
care system.96 In 1989, Spain introduced the National Transplant 
F IGURE  2 2015 deceased donor per 
million population rates in US and selected 
countries
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Organization (ONT), with implementation of transplant donor coor-
dinators (TDCs) in each hospital. TDCs are specially trained intensive 
care physicians or nurses charged with identifying potential donors 
and seeking authorization. The TDCs are monitored by a coordinated 
national Quality Assurance Program, which provides peer- review 
oversight of each institution and expedited performance improve-
ment initiatives.97 Many of the key features of the Spanish model, in-
cluding hospital- based donation coordinators and a quality assurance 
program, were implemented in Croatia with dramatic results, including 
a 2015 donation rate of 39 donors PMP.94 This demonstrates the re-
producibility of these important, but sometimes overlooked, Spanish 
model concepts.98
Israel has taken a different approach to increasing deceased 
donor authorization rates through incentivization. In 2008, the 
Israeli Parliament adopted a new law that gave priority to transplant 
candidates who had themselves registered to be an organ donor for 
at least 3 years before being listed as a candidate. Similar priority 
was given to transplant candidates with a first- degree relative who 
was a deceased organ donor, as well as to any previous live organ 
donor who subsequently required a transplant.99 Analysis of the 
Israeli deceased donation climate demonstrates that this program is 
associated with increased authorization rates for organ donation.100 
Similar laws exist in Singapore101 and Chile,102 although these sys-
tems differ from Israel’s initiative by including presumed- consent 
practices.
In countries where access to deceased donors is limited, the 
resulting desperation has led to accelerated innovation to provide 
organs for transplantation. In Japan and South Korea, transplant cen-
ters responded to this demand with large- scale innovation in living 
donor liver transplantation.103,104 The significant advances made in 
the course of developing these large- scale living donor liver trans-
plant programs have inspired similar innovation in North American 
centers.105 In South Africa, where transplant surgeons were faced 
with a large number of HIV- positive patients with end- stage renal 
disease and limited resources to care for them, innovation took the 
form of HIV- positive donor–to–HIV- positive recipient kidney trans-
plantation.106 The success of this program inspired investigation into 
the use of organs from HIV- positive donors in the United States.107 
Countries with inadequate access to standard DNDD donors have 
demonstrated innovation in the use of organs from DCDD donors. 
In the United Kingdom, the use of DCDD liver allografts from older 
donors has changed perceptions of the potential contributions of 
the DCDD donor pool to liver transplantation.108 Further, France, 
Spain, and the Netherlands have demonstrated successful utiliza-
tion of organs from uncontrolled (Maastricht categories II and V) 
donors, adding a previously unutilized group of potential donors to 
the pool.109-111 This work has led to the development of protocols 
in select US centers to explore improved utilization of these cate-
gories of organ donors.112,113 Finally, the Eurotransplant consortium 
began a senior program in 1999 to allow for better utilization of older 
donor kidneys in older recipients, with excellent results, suggesting 
that often- discarded older kidneys may be useful for well- selected 
older recipients.114
2.9 | Coalition and government
Several important national coalitions have been formed with the pur-
pose of increasing organ access. The US government plays an impor-
tant role in facilitating several of these coalitions via the Division of 
Transplantation (DoT) within the HRSA.115 The Advisory Committee 
on Organ Transplantation (ACOT), for example, was established by 
the Health and Human Services secretary to enhance organ donation 
and ensure the public that the transplantation system is grounded 
in best available medical science and is fair and equitable. Currently, 
ACOT has 5 active working groups that are actively examining de-
clining rates of organ donation and geographic barriers in organ dis-
tribution.116 The DoT also sponsored the DTCP, which conducted 
the Breakthrough Collaborative partially responsible for the large in-
crease in deceased organ donors from 2003 to 2006.2,3 The DTCP 
evolved into the independent organization The Organ Donation and 
Transplantation Alliance, commonly known as The Alliance, which 
continues to work toward increasing organ availability in a multi-
stakeholder fashion.117 Recent efforts from The Alliance include The 
Organ Donation Toolbox, which was developed to provide donor hos-
pitals and OPOs easy access to best practices resources.118 Further, 
in October 2016, the Alliance sponsored a multistakeholder National 
Critical Issues Forum to promote high- level, disruptive conversation 
aimed at changing the status quo in organ donation.119
Several large coalitions have been formed outside the US govern-
ment to unite stakeholders in an attempt to increase access to organs 
for transplantation. The National Coalition to Promote Living Kidney 
Donation combines the efforts of 15 nonprofit groups and OPOs to 
foster public policies that support living kidney donors and living kid-
ney donation, specifically through active lobbying of HRSA to publicly 
support efforts to increase live organ donation.120 Additionally, vari-
ous US transplant- related societies and nonprofit organizations have 
combined to form the Transplant Roundtable coalition. This coalition 
serves as a communications vehicle to prevent overlap in society- 
sponsored donation activities, and to provide direction for society- 
sponsored lobbyists who actively work to enhance US organ donation 
policies.121
3  | SUMMARY
In this white paper, the PROACTOR Task Force details numerous 
initiatives promoted by a wide variety of different stakeholders, each 
with the goal of increasing organ availability. When viewed optimisti-
cally, the sheer volume and diversity of organ access initiatives and 
the effort, attention, and resources directed toward this critical issue 
are encouraging. If one takes a pessimistic view, however, the fact 
that that these tremendous investments of time, energy, and assets 
have had only incremental impact on organ availability is discouraging.
As advocates for patients with organ failure, it is our obligation 
to remain unwaveringly optimistic and to continue to work toward 
the ultimate goal of eliminating mortality on the waitlist due to organ 
unavailability. Presented with an overwhelming number of potential 
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avenues toward this goal and an equally large number of partners with 
which to pursue it, it is imperative that we align the efforts of our 
members, our society, and our partners toward the highest- yield paths 
to increased organ access. Considering the wide scope of current ini-
tiatives outlined in this summary, as well as the heterogeneity of the 
environments in which they have been implemented, identifying the 
programs that truly “move the needle” can be difficult. Nevertheless, 
there are several common themes found within the current deceased 
and living donation and transplantation landscape that can inform the 
shaping of a more favorable future.
3.1 | Increasing deceased donation and organ 
utilization
The Centers for Disease Control and Prevention reported 8237 deaths 
PMP in the United States general population in 2014.122 Reconciling 
this figure with the US rate of 28.5 organ donors PMP in 2015 is so-
bering. Improving this metric will require a concerted multifaceted ap-
proach to improving organ donation and use.
3.1.1 | Increasing donor authorization
Much of the national conversation about increasing organ donation re-
volves around the concept that encouraging more people to say “yes” 
to organ donation is the key to saving lives on the waitlist. The promo-
tion of donor authorization is the primary public- facing message of the 
pro–organ donation movement. This is a reasonable public- education 
approach given that saying “yes” to donation is a much more acces-
sible concept to a layperson than increasing potential donor recogni-
tion, for example. Indeed, a substantial amount of effort and funding 
are directed toward improving authorization rates through the Donate 
Life America and state registries, minority outreach programs, large 
nonprofit efforts such as ORGANize, countless smaller nonprofits 
operating with slim budgets, and technology industry partnerships. 
Unfortunately, despite these intensive efforts and expenditures, the 
UNOS- reported eligible death authorization rate in 2016 was 75.0%, 
essentially unchanged from the rate of 75.4% in 2011.123
Our national focus on increasing authorization rates is the lens 
through which observations of successful international donation sys-
tems are sometimes misleadingly viewed. For example, many descrip-
tions of Spain’s success in donation focuses on the fact that they have 
a presumed consent system in place, ignoring the fact that many other 
nations with presumed consent models experienced decreased dona-
tion rates postimplementation.124 This incomplete understanding of 
Spain’s success has recently led to controversial government actions 
such as the “opt- out” bill recently proposed in the Texas legislature.125
The stagnation of authorization rates despite conventional and in-
creasingly unconventional means clearly indicates that applying even 
more focus to authorization is not the solution to our organ shortage 
crisis. Instead, a more comprehensive understanding of organ avail-
ability suggests that high rates of donor authorization are necessary, 
but not nearly sufficient, to substantially reduce waitlist mortality. 
Returning to the UNOS- reported 75.0% authorization rate in 2016, 
one can extrapolate that even an extraordinary authorization rate of 
90% of the same pool of referred eligible deaths in 2016 would result 
in 1994 more donors—a substantial increase for certain, but not nearly 
enough to dramatically change the course for patients on large wait-
lists such as the kidney waitlist.
To create impactful change on the waitlist, the current focus on the 
authorization- rate numerator (number of authorized donors) needs to 
be supplemented by a much more intense focus on increasing the de-
nominator (eligible death referrals). This work requires a 2- sided ap-
proach involving both (1) increased recognition of currently defined 
eligible deaths and (2) a utilization- driven change in the definition of 
eligible deaths.
3.1.2 | Increasing donor recognition
Prompt identification and referral of potential donors within hospi-
tals are critical steps in the deceased organ donation process. In Spain 
and Croatia, improving potential donor recognition via embedded in- 
hospital donation personnel has been essential to their world- leading 
productivity.97,98 The importance of this concept has long been rec-
ognized in the United States, and in- house OPO coordinator models 
were lauded as a best practice more than a decade ago as part of the 
Breakthrough Collaborative.2,3 Despite the success of this model, it 
has been inconsistently applied across the 58 US OPOs and may be, in 
part, responsible for their variable productivity. This important OPO 
practice should be supported by transplant providers as a mechanism 
to improve deceased donor recognition.
Although OPOs bear some responsibility for potential donor rec-
ognition, hospital care teams who make the referrals also bear respon-
sibility. Accordingly, transplant providers should partner with critical 
care teams at the local level to emphasize the importance of potential 
donor referral. Further, the ASTS and other transplant organizations 
should work at the society level with groups such as SCCM to help de-
velop systems to identify and close the gaps through which potential 
organ donors fall.
3.1.3 | Increasing organ utilization
The Deceased Donor Potential Study suggests that the true donor 
potential in the United States is 3 to 4 times the current number of 
recovered donors. Many of these donors come from categories of do-
nors currently defined as “nonstandard,” including DCDD donors and 
older DNDD donors, and are absent from current metrics regarding 
eligible deaths.44 The realization of the potential of the donor pool 
lies beyond the scope of simply referring and obtaining authorization 
from increasing numbers potential donors as currently defined. In fact, 
the key to unlocking this potential rests in our hands as transplant 
providers through our collective ability and willingness to use these 
“nonstandard” organs for our patients. Indeed, the primary driver of 
organ donation volume in the future is dependent on our transforma-
tive expansion of organ utilization.
Improved organ utilization starts with optimized management of 
the deceased donors and improved assessment of potential organ 
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function. On a broad level, the ASTS and other organizations must 
partner with SCCM, AOPO, and other stakeholders to improve the 
standards of donor management to increase the quantity and quality 
of organs recovered. Imperative to improving donor management is 
the resolution of barriers surrounding donor intervention trials, and 
full engagement with the National Academy of Medicine Committee 
on Issues in Organ Donor Intervention Research will serve as a critical 
step in this direction.
Organ utilization, and consequently the definition of what consti-
tutes an acceptable deceased donor, varies greatly among transplant 
centers. If the potential donor pool is to be maximized, knowledge and 
skills that facilitate the utilization of donor organs can no longer re-
main widely discrepant. At the society level, the ASTS can serve as a 
vehicle for disseminating training to reduce these gaps. For example, 
society- sponsored training courses or fellowships in the areas of pe-
diatric en-bloc kidney transplantation and split- liver transplantation 
may improve the broader acceptance of these techniques. Further, 
continuing to educate providers about the successful use of marginal 
organs such as older liver grafts and severe acute kidney injury renal 
grafts may help to reduce the prevalent risk aversion that so often 
prevents the acceptance of these transplantable organs.
DCDD donors are a rapidly growing component of the donor pool, 
comprising 17% of organ donors recovered in 2016.4 Despite the fact 
that 1 in 6 donors currently come from this category, the utilization 
gap for extrarenal organs from DCDD donors is striking. To truly create 
disruptive change in future deceased donor volume as suggested by 
the Deceased Donor Potential Study, better understanding and use 
of organs from DCDD donors are imperative.44 The ASTS is currently 
beginning focused efforts to improve DCDD organ utilization with 
the establishment of the DCDD Task Force in 2017. This task force, 
in collaboration with AOPO, seeks to standardize recovery parameters 
and recovery surgeon training to encourage improved DCDD organ 
utilization. Further, applying lessons learned from the international 
experience of older DCDD liver and uncontrolled DCDD kidney utili-
zation may help further maximize the potential of DCDD donation in 
the United States.
Industry’s contribution to organ utilization lies within the realm 
of emerging organ preservation and modification techniques. Early 
demonstrations of success with warm- liver perfusion and other de-
vices in other countries point toward a future in which the definition 
of a transplantable organ is changed. The US transplant community 
and its regulators should embrace the potential of these devices for 
changing waitlist mortality. Further, transplant centers, OPOs, and 
regulators on the local, society, and government levels need to be co-
operative to accommodate the proliferation of these potentially trans-
formative devices with respect to organ allocation and reallocation, 
definition of ischemia times, and other practical matters to help this 
technology thrive in the US environment.
Implicit in transplant provider and center reluctance toward ex-
panded organ utilization is concern regarding posttransplantation 
outcomes published in current center- specific reports. These reports, 
with their associated implications for regulatory and financial disin-
centives, are primary drivers of the risk- aversion that stifles innovation 
in organ utilization. Current efforts, such as the COIIN project, are 
welcome steps in the right direction to allow for the exploration of 
ways to expand organ utilization. Future efforts, including the ASTS/
AST/Arnold Foundation projects, may result in the development of 
transplant center metrics that will improve utilization by reducing risk- 
aversion and rewarding, rather than penalizing, centers for expanding 
the reach of transplantation.
Finally, organ allocation systems have long been the topic of much 
debate in the transplant community, but the role of these systems in 
improving organ utilization is underdiscussed. Balancing the Final Rule 
principles of fair organ distribution and “achieving the best use of do-
nated organs” is difficult, especially because even small changes re-
lated to allocation methods or organ descriptions may have unintended 
consequences that can lead to diminished organ use.126,127 In fact, the 
early results of the 2014 Kidney Allocation System, designed in part to 
improve organ use, resulted in a slight early decrease in kidney use.128 
Additional mechanisms such as expedited organ allocation designed 
to improve utilization have been demonstrated internationally,129,130 
as well as preferential allocation of older kidneys to older recipients to 
promote use such as the Eurotransplant Senior Program.114 Perhaps 
pilot studies of these programs in the United States will demonstrate 
similar favorable results to drive improved organ acceptance and use.
None of these mechanisms in isolation can result in drastic correc-
tion of the deceased donor organ shortage, but together they can have 
a synergistic effect. For example, suppose that a liver from an elderly 
DCDD donor, recovered by a well- trained surgeon and placed on a 
warm- perfusion device, is allocated to a low- MELD recipient based 
on a utilization- prioritizing system in a less risk- averse regulatory en-
vironment. The liver is then transplanted successfully into the appro-
priately consented recipient, who might otherwise not have access to 
a transplantable organ. This experience is reported by the transplant 
team, encouraging other centers to expand their use of DCDD liver 
grafts. At the donor hospital, use of this organ encourages the criti-
cal care team and embedded OPO staff to better recognize and refer 
similar potential donors in the future, and the donor family becomes 
advocates to help improve authorization rates in their community. This 
is the cycle of success that, as transplant providers, we are responsible 
for initiating.
3.2 | Increasing living donation
The past 10 years has been marked by significant strides in living 
donor organ transplantation. Experience with ABO- incompatible 
and crossmatch- positive living donor kidney transplantation, as well 
as the widespread acceptance of paired- kidney donation, has re-
duced or removed immunologic barriers for many potential donor–
recipient pairs. Social media and related technologies support the 
maintenance of intrapersonal relationships and creation of new ones 
and give voice and a wide audience to those who might be seeking 
a living donor. The National Living Donor Assistance Center has be-
come established to facilitate disincentive- reduction, and major pay-
ors starting with United Healthcare have begun to follow suit with 
their own programs. Living donor liver transplantation has modestly 
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expanded over the past 6 years, and lessons learned from the inter-
national experience are being applied in the United States. Despite 
these important advances, the 5979 total living US organ donors in 
2016 represents a striking decrease from the peak of 7004 in 2004.4 
This is a disturbing trend that is difficult to reconcile, and it may 
be due in part to changing characteristics of the recipient popula-
tion, deceased donor organ distribution, financial concerns, or other 
poorly understood factors.131
Considering the new tools at our disposal, transplant providers, 
centers, societies, and regulatory bodies must work in partnership to 
thoughtfully expand living donation to better serve the needs of the 
organ- failure population. At the transplant provider and center levels, 
implementation of new strategies that have been shown to be effec-
tive such as the Live Donor Champion Program75 and House- Calls 
program76 should be further expanded. At the society level, surgical 
education regarding best practices such as the ASTS Laparoscopic 
Donor Nephrectomy Workshop should be continued. Novel initiatives, 
such as using deceased donor kidneys to initiate living donor chains, 
should be explored.132 Additionally, the ASTS should facilitate surgi-
cal education in living donor liver transplantation through programs at 
high- volume centers in North America and overseas.
Removing disincentives to living donation has been a collaborative 
project of the ASTS with other stakeholders, and these efforts should 
continue to help reshape the landscape of living donation in the United 
States. The year 2016 was important in this regard, with passage of the 
Living Donor Protection Act. This momentum should carry the society 
toward further breakthroughs in the coming years through participa-
tion in a Living Donor Breakthrough Collaborative suggested by The 
National Coalition to Promote Living Kidney Donation. This proposed 
initiative would complement the recent HRSA/SRTR development of 
The Living Donor Collective Scientific Registry to better understand 
living donor risks, outcomes, and other issues relevant to living dona-
tion expansion.133
In summary, the future of our society, our profession, and, most 
importantly, our patients is dependent on the availability of organs 
for transplantation. The vision of the ASTS is to save and improve 
lives through transplantation, and to realize this vision, we must all 
play a role in reducing the organ shortage. We call on every trans-
plant provider, the ASTS, and all stakeholders in our field to rededi-
cate themselves toward this vision through individual and collective 
efforts so that one day soon the promise of transplantation can be 
fully achieved.
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